-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

652.P1.53 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster I

Symposia: MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Antibody Therapy, Viral, Combination therapy, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Drug development, Translational Research, Epidemiology, Autoimmune hemolytic anemia, Assays, Elderly, Chemotherapy, Plasma Cell Disorders, Clinical Research, Health outcomes research, Diversity, Equity, and Inclusion (DEI), Education, Diseases, Immune Disorders, Patient-reported outcomes, Treatment Considerations, Infectious Diseases, Biological therapies, Immunology, Immunotherapy, Real-world evidence, Clinical procedures, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Registries, Biological Processes, Emerging technologies, Monoclonal Antibody Therapy, Survivorship, Technology and Procedures, Study Population, Human, Imaging, Machine learning, Transplantation (Allogeneic and Autologous), Molecular testing, Omics technologies, Serologic Tests
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Jonathan S. Wall, PhD1*, Stephen J. Kennel, PhD1*, Alan Stuckey, CNMT1*, Bryan Whittle, CNMT2*, Joseph W. Jackson, PhD1*, Angela D. Williams, MS1*, Trevor Hancock, PhD1*, R. Eric Heidel, PhD1*, Muddassir Mehmood, MD2*, Anne Kassira, MD2*, Ronald H. Lands, MD1, Hannah Watson2*, Rebecca Hung, MD, PhD3* and Emily B Martin, PhD1*

1University of Tennessee Health Science Center College of Medicine, Knoxville, TN
2University of Tennessee Medical Center, Knoxville, TN
3Vanderbilt University Medical Center, Nashville, TN

John Hanna, MD1, Ryan Brown, MD1*, Zain Ali Burney, MD1*, Kawther Abdallah, MD1*, Jason Valent, MD2, Christy J. Samaras, DO2, Faiz Anwer, MD2, Jack Khouri, MD2, Louis Williams, MD2, Shahzad Raza, MD2, Willem Van Heeckeren, MD, PhD2* and Sandra Mazzoni, DO2*

1Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
2Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Victor H. Jimenez-Zepeda, MD1, Irwindeep Sandhu, MD2*, Michael P. Chu, MD3, Kathryn Rankin4*, Arleigh McCurdy, MD5, Hyra Sapru, MD5, Christopher Cipkar, MD, BSc5*, Edward Koo5*, Benjamin Patrick5*, Sarah Albert5*, Meriem Henia6*, Christopher McCudden7* and Alissa Visram, MD, MPH8

1Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada
2University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada
3Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
4Cancer Care Alberta, Alberta Health Services, Edmonton, AB, Canada
5The Ottawa Hospital, Ottawa, ON, Canada
6University of Ottawa, Ottawa, ON, Canada
7Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada
8Division of Hematology, The Ottawa Hospital Research Institute, Ottawa, ON, Canada

Sandra CM Quinn, PhD, BA1* and Danielle Romaniuk2*

1Research and Advocacy, Myeloma UK, Edinburgh, SCO, United Kingdom
2Research and Advocacy, Myeloma UK, Edinburgh, Scotland, United Kingdom

Divaya Bhutani, MD1,2, Rajshekhar Chakraborty, MD2, Suzanne Lentzsch, MD, PhD2,3, Meghan Sise, MD, MS4*, Elizabeth Shelton5*, Emily Simone6*, Naomi Sender7*, Sherley Mejia8* and Shayan Shirazayan9*

1Herbert Irving Comprehensive Cancer Center, Columbia University medical center, New York, NY
2Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
3Columbia University Irving Medical Center, New York Presbyterian, New York, NY
4Division of Nephrology, Massachusetts General Hospital, Boston, MA
5columbia university medical center, New York
6Columbia University Medical Center, New YorK
7Columbia University, New York, NY
8Mass General Hospital, Boston
9Columbia University Medical Center, New York

Romain Stammler, MD1*, Yannick Dieudonné2*, Florence Delestre3*, Boris Sorin4*, Bertrand Dunogué3*, Silene Knapp5*, Gregoire Martin De Fremont6*, Benjamin Fournier, MD; PhD7*, Anthony Vanjak6*, Veronique Meignin, MD8*, Emilie Corvilain, MD9*, Emmanuel Lafont10*, Thibault Mahevas11*, Laurence Gerard, MD12*, Lionel Galicier13*, Celeste Lebbe14*, Eric Oksenhendler13*, Sylvain Latour15* and David Boutboul, MD, PhD1,16*

1Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, Paris, France
2Strasbourg University Hospital, Strasbourg, FRA
3Internal Medicine, Hopital Cochin Université Paris Cité, Paris, France
4Internal Medicine, Hopital Cochin Université Paris Cité, Paris, FRA
5Hematology, Hopital Cochin, Paris, FRA
6U976 HIPI, Paris, FRA
7Necker Hospital (APHP), Paris, France
8Pathology, Hopital Saint-Louis, PARIS, FRA
9Hôpital Saint-Louis, APHP, Paris, France
10Assistance Publique -hopitaux De Paris, Paris, FRA
11Dermatology, Hôpital Saint Louis, Paris, France
12Hôpital Saint-Louis, Paris, France
13Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, France
14Hopital Saint Louis, Paris, FRA
15Instutut IMAGINE, Hôpital Necker, Paris, FRA
16Department of Hematology, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France

Uday Yanamandra, MD, DM1,2, Harikrishnan Premdeep, MD3*, J Muthukrishnan, MD4*, Narendra Kotwal5*, Pankaj Malhotra, MD6,7,8, Velu Nair, MBBS, MD9,10 and Shaji Kumar, MD11,12

1Internal Medicine and Hematology, Armed Forces Medical College, Pune, IND
2Internal Medicine and Hematology, Armed Forces Medical College, Pune, India
3INTERNAL MEDICINE, ARMED FORCES MEDICAL COLLEGE, PUNE, India
4Internal Medicine, Armed Forces Medical College, Pune, India
5Armed Forces Medical College, Pune, India
6Postgraduate Institute of Medical Education and Research, Chandigarh, India
7Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
8Department of Clinical Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India
9Apollo Hospitals Ahmedabad, Detrojrampura, Gujarat, India
10Apollo Hospitals Ahmedabad, Detrojrampura, Gujarat, IND
11Division of Hematology, Mayo Clinic, Rochester, MN
12Mayo Clinic, Rochester, MN

Yannick Dieudonné1*, Clement Gourguechon2*, Romain Stammler, MD3*, Florence Delestre4*, Boris Sorin5*, Bertrand Dunogué4*, Guillaume Dumas6*, Guillemette Fouquet, MD, PhD7*, Anne Marie Ronchetti8*, Romain Paule9*, Pascal Meliani10*, Nathalie Pansu11*, Rodolphe Buzele12*, Robin Noel, MD13*, Jehane Fadlallah14*, Emilie Corvilain, MD15*, Marion Malphettes16*, Laurence Gerard, MD17*, Veronique Meignin18*, Constance Guillaud19*, Antoine Dossier20*, Jeremie Dion21*, Eric Oksenhendler14*, Lionel Galicier22* and David Boutboul, MD, PhD3,23*

1Strasbourg University Hospital, Strasbourg, FRA
2Amiens University Hospital, Amiens, France
3Department of Hematology, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France
4Internal Medicine, Hopital Cochin Université Paris Cité, Paris, France
5Internal Medicine, Hopital Cochin Université Paris Cité, Paris, FRA
6Intensive Care Unit, CHU Grenoble, Grenoble, France
7Hematology Department, Hospital Sud Francilien, Corbeil-Essonnes, France
8CH Sud Francilien, Hematology Department, Corbeil Essonne, France
9Hopital Foch, Suresnes, FRA
10CH Mayotte, Mayotte, France
11Tropical and Infectious Diseases University Hospital, Montpellier Cedex 5, Franc, Montpellier, FRA
12Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, France
13Institut Paoli-Calmettes, Marseille, FRA
14Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, France
15Hôpital Saint-Louis, APHP, Paris, France
16Saint Louis Hospital, Paris, France
17Hôpital Saint-Louis, Paris, France
18Assistance Publique - Hôpitaux de Paris (APHP), Pathology; Paris University. Paris, Paris, France
19Hôpital Henri Mondor, Créteil, France
20Internal Medicine, Hôpital Bichat, Paris, France
21Toulouse University Hospital, Toulouse, France
22Centre de Réference National Maladie de Castleman, Paris, France
23Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, Paris, France

Louis Williams, MD1, Danai Dima, MD2, Hanny Sawaf, MD3*, Ali Mehdi, MD, M.Ed.3*, Daniel Cancilla, MD4, Hira Shaikh, MD5, Faiz Anwer, MD6, Sandra Mazzoni, DO7, Beth M. Faiman, PhD, CNP6, Jack Khouri, MD6, Christy J. Samaras, DO8, Jason Valent, MD6 and Shahzad Raza, MD6

1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2University of Washington, Seattle, WA
3Cleveland Clinic Foundation, Cleveland, OH
4Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
5University of Iowa Caver College of Medicine, Coralville, IA
6Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
7Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
8Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland

Hassan Kawtharany1*, Muayad Azzam, MD2*, Jamil Nazzal, MD3*, Vishal Kukreti, MD, MSc4, Matthew D. Seftel, MD, FRCP, FRCPC, MPH5, Qais Hamarsha, MD3*, Aseel Alkhader, MD3*, Tala Khraise, MD6*, Mohammad Mahmoud AlMasri, MD7*, Hadi Khaled Abou Zeid, MD8*, Iktimal Alwan, MD9*, Mhd Amin Alzabibi, MD10*, Noor Jaber3*, Laura Darwish11*, Faizi Jamal, MD12*, Noel Dasgupta, MD13*, Nitasha Sarswat, MD14*, Alfredo H. De La Torre, MD15, Maria Adela Aguirre, MD, PhD16*, Deborah Boedicker17*, Naresh Bumma, MD18, Antonia Carroll, MD19*, Raymond Comenzo, MD20, Joselle Cook, MBBS21, Angela Dispenzieri, MD21, Jack Khouri, MD22, Maria M. Picken, MD, PhD23*, Shahzad Raza, MD22, Nelson Leung, MD21, Vaishali Sanchorawala24, Hira Shaikh, MD25, Daulath Singh, MD26* and Reem A Mustafa, MD, PhD, MPH27*

1Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center
2Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Merriam, KS
3Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Department of Medicine, University of British Columbia, Vancouver, CAN
6Northwest Health, Porter County, IN
7King Hussein Cancer Center, Amman, Jordan
8University of Balamand, Balamand, Lebanon
9AdventHealth, Tampa
10Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
11Blue Valley Southwest, Kansas city
12Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
13Indiana University School of Medicine, Indianapolis, IN
14Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
15QEII Health Sciences Centre, Halifax, NS, CAN
16Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
17Mackenzie’s Mission, Great Falls, VA
18The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
19Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
20Tufts Medical Center, Boston, MA
21Division of Hematology, Mayo Clinic, Rochester, MN
22Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
23Loyola University Medical Center, Maywood, IL
24Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
25Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
26Mission Cancer + Blood, Des Moines, IA
27Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Muayad Azzam, MD1*, Hassan Kawtharany2*, Jamil Nazzal, MD3*, Vishal Kukreti, MD, MSc4, Matthew D. Seftel, MD, FRCP, FRCPC, MPH5, Aseel Alkhader, MD3*, Qais Hamarsha, MD3*, Tala Khraise, MD6*, Mohammad Mahmoud AlMasri, MD7*, Hadi Khaled Abou Zeid, MD8*, Iktimal Alwan, MD9*, Noor Jaber3*, Mohammad Fraitekh10*, Noel Dasgupta, MD11*, Raymond Comenzo, MD12, Faizi Jamal, MD13*, Maria Adela Aguirre, MD, PhD14*, Deborah Boedicker15*, Naresh Bumma, MD16, Antonia Carroll, MD17*, Joselle Cook, MBBS18, Alfredo H. De La Torre, MD19, Angela Dispenzieri, MD18, Jack Khouri, MD20, Nelson Leung, MD18, Maria M. Picken, MD, PhD21*, Shahzad Raza, MD20, Vaishali Sanchorawala22, Hira Shaikh, MD23, Nitasha Sarswat, MD24*, Daulath Singh, MD25* and Reem A Mustafa, MD, PhD, MPH26*

1Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Merriam, KS
2Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center
3Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Department of Medicine, University of British Columbia, Vancouver, CAN
6Northwest Health, Porter County, IN
7King Hussein Cancer Center, Amman, Jordan
8University of Balamand, Balamand, Lebanon
9AdventHealth, Tampa
10Blue Valley West, Overland Park, KS
11Indiana University, Bloomington, IN
12Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
13Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
14Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
15Mackenzie’s Mission, Great Falls, VA
16The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
17Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
18Division of Hematology, Mayo Clinic, Rochester, MN
19QEII Health Sciences Centre, Halifax, NS, CAN
20Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
21Loyola University Medical Center, Maywood, IL
22Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
23Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
24Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
25Mission Cancer + Blood, Des Moines, IA
26Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Alexa Loncharich, MD1, Mark Fiala, PhD2*, Julie Fortier, PhD2*, Keith Stockerl-Goldstein, MD3, Ravi Vij, MD, MBA3, Mark A. Schroeder, MD3, Mark Zaydman, MD, PhD4, Michael Slade, MD, MS3 and Mariya Liyasova, PhD5*

1Washington University School of Medicine in St. Louis, St Louis, MO
2Division of Oncology, Washington University School of Medicine, Saint Louis, MO
3Division of Oncology, Washington University School of Medicine, St. Louis, MO
4Division of Pathology, Washington University School of Medicine, St Louis, MO
5Rapid Novor Inc., Kitchener, ON, Canada

Abdullah Faisal Deen1*, Qaiser Bashir, MD1, Neeraj Y. Saini, MD1, Yosra M. Aljawai, MD, MS2, Chitra Hosing, MD1, Uday Popat, MD1, Melody R. Becnel, MD3, Gregory P. Kaufman, MD3*, Sheeba K. Thomas, MD3, Donna M. Weber, MD4, Robert Z. Orlowski, MD, PhD4, Elizabeth J. Shpall, MD1, Richard E. Champlin, MD1, Muzaffar H. Qazilbash, MD1 and Samer A. Srour, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Sophiya S Sami1*, Qaiser Bashir, MD1, Neeraj Y. Saini, MD1, Yosra M. Aljawai, MD, MS1, Chitra Hosing, MD1, Uday Popat, MD1, Melody R. Becnel, MD2, Gregory P. Kaufman, MD2*, Sheeba K. Thomas, MD2, Donna M. Weber, MD2, Robert Z. Orlowski, MD, PhD2, Richard E. Champlin, MD1, Elizabeth J. Shpall, MD1, Muzaffar H. Qazilbash, MD1 and Samer A. Srour, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Omer Ashruf1*, Ali Mushtaq, MD2, Faiza Zakaria, MBBS3*, Razwana Khanam, MD4* and Faiz Anwer, MD5

1College of Medicine, Northeast Ohio Medical University, Solon, OH
2Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
3Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
4Department of Hematology & Oncology, Medical University of South Carolina, Charleston, SC
5Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Jamil Nazzal, MD1*, Muayad Azzam, MD2*, Hassan Kawtharany3*, Vishal Kukreti, MD, MSc4, Matthew D. Seftel, MD, FRCP, FRCPC, MPH5,6, Aseel Alkhader, MD7*, Tala Khraise, MD8*, Qais Hamarsha, MD7*, Hadi Khaled Abou Zeid, MD9*, Iktimal Alwan, MD10*, Mohammad Mahmoud AlMasri, MD11*, Noor Jaber7*, Vaishali Sanchorawala12, Joselle Cook, MBBS13, Jack Khouri, MD14, Angela Dispenzieri, MD13, Maria M. Picken, MD, PhD15*, Maria Adela Aguirre, MD, PhD16*, Hira Shaikh, MD17, Shahzad Raza, MD18, Antonia Carroll, MD19*, Deborah Boedicker20*, Naresh Bumma, MD21, Raymond Comenzo, MD22, Noel Dasgupta, MD23*, Daulath Singh, MD24*, Alfredo H. De La Torre, MD25, Nitasha Sarswat, MD26*, Nelson Leung, MD13, Faizi Jamal, MD27* and Reem A Mustafa, MD, PhD, MPH28*

1Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, KANSAS CITY, AL
2Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Merriam, KS
3Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5CancerCare, Vancouver, BC, Canada
6Department of Medicine, University of British Columbia, Vancouver, CAN
7Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
8Northwest Health, Porter County, IN
9University of Balamand, Balamand, Lebanon
10AdventHealth, Tampa
11King Hussein Cancer Center, Amman, Jordan
12Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
13Division of Hematology, Mayo Clinic, Rochester, MN
14Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
15Loyola University Medical Center, Maywood, IL
16Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
17Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
18Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Overland Park, KS
19Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
20Mackenzie’s Mission, Great Falls, VA
21The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
22Tufts Medical Center, Boston, MA
23Indiana University, Bloomington, IN
24Mission Cancer + Blood, Des Moines, IA
25QEII Health Sciences Centre, Halifax, NS, CAN
26Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
27Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
28Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Hassan Kawtharany1*, Muayad Azzam, MD2*, Jamil Nazzal, MD3*, Vishal Kukreti, MD, MSc4, Matthew D. Seftel, MD, FRCP, FRCPC, MPH5, Qais Hamarsha, MD3*, Aseel Alkhader, MD3*, Tala Khraise, MD6*, Mohammad Mahmoud AlMasri, MD7*, Hadi Khaled Abou Zeid, MD8*, Iktimal Alwan, MD9*, Mhd Amin Alzabibi, MD10*, Noor Jaber3*, Alfredo H. De La Torre, MD11, Noel Dasgupta, MD12*, Nitasha Sarswat, MD13*, Faizi Jamal, MD14*, Maria Adela Aguirre, MD, PhD15*, Deborah Boedicker16*, Naresh Bumma, MD17, Antonia Carroll, MD18*, Raymond Comenzo, MD19, Joselle Cook, MBBS20, Angela Dispenzieri, MD20, Jack Khouri, MD21, Maria M. Picken, MD, PhD22*, Shahzad Raza, MD21, Nelson Leung, MD20, Vaishali Sanchorawala23, Hira Shaikh, MD24, Daulath Singh, MD25* and Reem A Mustafa, MD, PhD, MPH26*

1Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center
2Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Merriam, KS
3Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Department of Medicine, University of British Columbia, Vancouver, CAN
6Northwest Health, Porter County, IN
7King Hussein Cancer Center, Amman, Jordan
8University of Balamand, Balamand, Lebanon
9AdventHealth, Tampa
10Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
11QEII Health Sciences Centre, Halifax, NS, CAN
12Indiana University School of Medicine, Indianapolis, IN
13Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
14Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
15Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
16Mackenzie’s Mission, Great Falls, VA
17The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
18Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
19Tufts Medical Center, Boston, MA
20Division of Hematology, Mayo Clinic, Rochester, MN
21Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
22Loyola University Medical Center, Maywood, IL
23Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
24Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
25Mission Cancer + Blood, Des Moines, IA
26Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Efstathios Kastritis, MD, PhD1*, Giovanni O. Palladini, MD, PhD2, Meletios-Athanasios Dimopoulos1, Arnaud Jaccard, MD, PhD3*, Giampaolo Merlini, MD, PhD2*, Foteini Theodorakakou, MD1*, Despina Fotiou, MD1*, Monique C Minnema4*, Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath5, Stavros Golfinopoulos, MD, MSc, MBA6*, Nasia Antoniou, MSc, PhD6*, Giorgos Psarros, MSc6*, Pieter Sonneveld, MD7 and Stefan Schonland8*

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2Amyloidosis Research and Treatment Center, University of Pavia, Pavia, Italy
3Referral Center for AL Amyloidosis, Limoges, France
4Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
5Clinical Haematology, Cancer Division, University College London Hospital, London, United Kingdom
6Health Data Specialists, Dublin, Ireland
7Erasmus MC Cancer Institute, Rotterdam, Netherlands
8Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany

Mario Nuvolone, MD, PhD1,2*, Ute Hegenbart, MD3*, Bruno Paiva, PhD4*, Monique C. Minnema5, Enkelejda Miho6,7,8*, Marta Lasa9*, Paolo Milani, MD, PhD1,2, Alain van Mil, PhD10*, Marish I. F. Oerlemans, MD11,12*, Jan Kruta7*, Ramon Lecumberri Villamediana, MD, PhD13*, Alice Nevone, PhD1,2*, Luca Arcaini, MD2,14*, Francesca Gay, MD, PhD15, Francesco Di Raimondo, MD, Prof16, Pellegrino Musto17*, Eloisa Riva, MD, MEd18, Mohammed Aljama, MBBS, FRCPC19*, Krzysztof Jamroziak, MD, PhD20*, Roberta Shcolnik Szor, MD21*, Mathias Brehon, MD22*, Giampaolo Merlini, MD, PhD1,2*, Stefan Schonland3* and Giovanni O. Palladini, MD, PhD1,2

1Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
2Department of Molecular Medicine, University of Pavia, Pavia, Italy
3Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany
4Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain
5Department of Hematology, UMC Utrecht, Utrecht, Netherlands
6SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
7School of Life Sciences, FHNW University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
8aiNET GmbH, Basel, Switzerland
9Clinica Universidad De Navarra, Centro De Investigacion Medica Aplicada (CIMA),, Pamplona, Spain
10Laboratory of Experimental Cardiology, Regenerative Medicine Center, UMC Utrecht, Utrecht, Netherlands
11Department of Cardiology, UMC Utrecht, Utrecht, Netherlands
12Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Utrecht, Netherlands
13Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBER-ONC CB16/12/00369, Pamplona, Spain, Spain, Pamplona, Spain
14Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
15Division of Hematology 1, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
16Haematology, AOU Policlinico G. Rodolico-San Marco, University School of Medicine, Catania, Italy, CATANIA, ITA
17Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine,and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Bari, Italy
18University of the Republic, Hospital De Clínicas Dr. Manuel Quintela, Montevideo, Uruguay
19Department of Oncology, McMaster University, Hamilton, Canada
20Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warszawa, Poland
21Hospital Nove de Julho, DASA, São Paulo, Brazil
22Médipôle Lyon-Villeurbanne, Villeurbanne, FRA

Aditi Sharma, MD1, Joel Topf, MD2*, Christiane A. Houde, BS1*, Cathy Galasso1*, Sarah Phillips, BS1*, Carmen Mitteer1*, Amanda Guido1*, Lori McFadden2*, Katelyn Staub, RN1*, Amy Blake, NP1*, Joseph Ellul, NP1*, Andrew Kin, MD1, Craig Emmitt Cole, MD1, Abhinav Deol, MD1*, Joseph Schiavi, R.Ph.1*, Seongho Kim, PhD1* and Jeffrey A. Zonder, MD 3

1Karmanos Cancer Institute/Wayne State University, Detroit, MI
2Wayne State University, Detroit, MI
3Karmanos Cancer Institute, Detroit, MI

*signifies non-member of ASH